Eva J.A. van Wanrooij

Author

Leiden University

Also Known As

E. J.A. van Wanrooij, E.J.A. van Wanrooij, Eva J. A. van Wanrooij, Eva J.A van Wanrooij, Eva J.A. van Wanrooij

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Leiden University Leiden University Medical Center

About

Eva J.A. van Wanrooij is an author at Leiden University specializing in vascular biology, atherosclerosis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	129
2	Health Sciences	1	1	92
3	Immunology	1	1	37
4	Aging	1	1	92
5	Hematology	1	1	92

Eva J.A. van Wanrooij

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis Gijs H.M. van Puijvelde, T. van Es, Eva J.A. van Wanrooij, Arteriosclerosis Thrombosis and Vascular Biology	2007	174
CXCR3 Antagonist NBI-74330 Attenuates Atherosclerotic Plaque Formation in LDL Receptor–Deficient Mice Eva J.A. van Wanrooij, Saskia C.A. de Jager, Thomas van Es, Arteriosclerosis Thrombosis and Vascular Biology	2007	121
KLF2 Suppresses TGF-β Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 Reinier A. Boon, Joost O. Fledderus, Oscar L. Volger, Arteriosclerosis Thrombosis and Vascular Biology	2006	116
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice Kim L. L. Habets, Gijs H.M. van Puijvelde, Leonie M. van Duivenvoorde, Cardiovascular Research	2009	113
Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) Pathway Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice Eva J.A. van Wanrooij, Gijs H.M. van Puijvelde, Paul de Vos, Arteriosclerosis Thrombosis and Vascular Biology	2006	110
HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice Eva J.A. van Wanrooij, H. Kevin Happe, Arnaud D. Hauer, Arteriosclerosis Thrombosis and Vascular Biology	2005	104
HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes Illiana Meurs, Menno Hoekstra, Eva J.A. van Wanrooij, Experimental Hematology Metabolic SyndromeImportant FactorOxysterolAgingCardiovascular Disease	2005	92
Vaccination Against VEGFR2 Attenuates Initiation and Progression of Atherosclerosis Arnaud D. Hauer, Gijs H.M. van Puijvelde, Niels Peterse, Arteriosclerosis Thrombosis and Vascular Biology	2007	80
Repopulation of Apolipoprotein E Knockout Mice With CCR2-Deficient Bone Marrow Progenitor Cells Does Not Inhibit Ongoing Atherosclerotic Lesion Development Jian Guo, Vivian de Waard, Miranda Van Eck, Arteriosclerosis Thrombosis and Vascular Biology	2005	44
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice Thomas van Es, Gijs H.M. van Puijvelde, Ingrid Michon, Vaccine	2010	41

Page 1